Get more info on this report!The World Market for Molecular DiagnosticsJanuary 1, 2009Molecular diagnostics represents a r...
Microarrays       Laser Capture Microdissection (LCM) and Tissue Arrays       Mass Spectroscopy       Other Molecular Plat...
dollar value of a market segment is directly proportional to the number of testsperformed, because the cost of the instrum...
AffymetrixAgendia B.V.Agilent Technologies Inc.Almac Diagnostics (formerly ArraDx)Althea Technologies, Inc.Ambry Genetics ...
Fluidigm CorporationFocus Diagnostics, Inc.Fujifilm Diagnostics (Fujifilm GmbH)Gene Express, Inc.GeneNews LimitedGenoID Lt...
Osmetech plc    Pacific Biosciences of California, Inc. (PacBio)    ParagonDx LLC    Pathwork Diagnostics (formerly Predic...
CHAPTER TWO: TECHNOLOGICAL TRENDS    Background    The In Vitro/In Vivo Mix    Miniaturization and Multiplexed Biological ...
o Transcription Factors        o Circulating Cell-free Nucleic Acids     Sample Preparation and System Automation     Home...
o Trends in Transfusion Medicine        o Blood Screening Markets        o PROCLEIX     The Market for Molecular Assays in...
CHAPTER NINE: MAJOR VENDORS AND COMPANIES TO WATCH    Top Companies    Abbott Diagnostics       o Revenues       o Key Com...
o  DetailsOrtho Clinical Diagnostics (OCD)   o Revenues   o Key Comment   o DetailsQiagen N.V.   o Revenues   o Key Commen...
o   Key Comment   o   DetailsAdvanDx, Inc.    o Revenues    o Key Comment    o DetailsAffymetrix    o Revenues    o Key Co...
AutoGenomics, Inc.   o Revenues   o Key Comment   o DetailsAviaraDx (formerly Arcturus Biosciences)   o Revenues   o Key C...
o   Key Comment   o   DetailsClarient Inc. (formerly ChromaVision)    o Revenues    o Key Comment    o DetailsClinical Dat...
DNA Direct, Inc.   o Revenues   o Key Comment   o DetailsThe DNA Repair Company (DNAR)   o Revenues   o Key Comment   o De...
o    Key Comment   o    DetailsExiqon A/S    o Revenues    o Key Comment    o DetailsFluidigm Corporation    o Revenues   ...
Hain Lifescience GmbH    o Revenues    o Key Comment    o DetailsHamilton Thorne Biosciences, Inc.    o Revenues    o Key ...
o    Key Comment   o    DetailsInvitrogen Corporation     o Revenues     o Key Comment     o DetailsIpsogen     o Revenues...
Monogram Biosciences, Inc. (formerly ViroLogic)   o Revenues   o Key Comment   o DetailsMyconostica, Ltd.   o Revenues   o...
o   Key Comment   o   DetailsOrion Genomics   o Revenues   o Key Comment   o DetailsOsmetech plc   o Revenues   o Key Comm...
Q Chip Ltd.   o Revenues   o Key Comment   o DetailsQuest Diagnostics Incorporated   o Revenues   o Key Comment   o Detail...
o    Key Comment          o    Details       Transgenomic Inc.           o Revenues           o Key Comment           o De...
US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004
Upcoming SlideShare
Loading in …5
×

World Market for Molecular Diagnostics , The

654 views
604 views

Published on

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
654
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
32
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

World Market for Molecular Diagnostics , The

  1. 1. Get more info on this report!The World Market for Molecular DiagnosticsJanuary 1, 2009Molecular diagnostics represents a revolution postponed, perhaps, but one that is nowclearly underway. DNA Testing has emerged fully from research into clinical practiceand becoming a dominant platform in clinical medicine.From Emerging to Emergent TechnologyInstrumentation now automates many of the sample preparation and assay steps thatwere formerly labor intensive. New tests are being launched all the time. At each step ofthe way, Kalorama Information has reported on its progress, and in this latest marketresearch report we look at the present state of the market, and the advances that havemade DNA testing routine.Many molecular tests are CE Marked and FDA-cleared and many more are indevelopment. The result is that molecular testing is indicated in many areas of healthcare.Molecular Testing Compiled and Analyzed and Explained by a Leading ExpertAuthored by lead Kalorama diagnostic analyst Shara Rosen, Kalorama InformationsWorld Market for Molecular Diagnostics is the most comprehensive global market reportavailable on the emergent field of molecular diagnostics.This report covers key platforms of molecular diagnostics, including the following : Polymerase Chain Reaction (PCR) Non-PCR Amplification Technologies, including: o bDNA o TMA o SDA o LIPA o NASBA o Invader o Others In-situ Hybridization Sequencing
  2. 2. Microarrays Laser Capture Microdissection (LCM) and Tissue Arrays Mass Spectroscopy Other Molecular PlatformsThis report provides market estimates and analysis for molecular diagnostics in thefollowing categories: Infectious Diseases (including HIV, Hepatitis GC/Chlamydia,Organism ID, MRSA, HAI et al, Mycobacteria, TB Respiratory, Others) Blood Screening Histology Oncology Prenatal Coagulation Tissue Typing Inherited Diseases PharmacodiagnosticsThe various clinical techniques and trends are discussed from the point of view of theirpresent and potential market impact.Market analysis in this report covers world markets for in vitro diagnostics, with focus onthe developed areas of the globe -- North America and Western Europe. Howeverpublic health and infectious disease are a growing global problem and where possiblethe report covers IVD products related to the globalization of diseases.As part of its exhaustive coverage of nucleic acid testing, the report includes thefollowing: Market Sizes and Forecasts Profile and Assessment of Over 140 Key Competitors Breakout of Molecular Diagnostic Market by Region (N. America, W. Europe, Asia, ROW) Medical and Technological Trends Discussion of Globalization of Markets and Diseases Information on Reimbursement of New Technologies Review of Novel Test Platforms Review of New Market Developments, Such as Consumer Genomics and Testing Services Discussion of Market Impact of Home Brew Tests Discussion of Diagnostic Biomarkers and Genetic IndicatorsAll market data are based on factory sales to the end user and not retail pricing orreimbursement payments. Data for the molecular test market are presented in U.S.dollar market size for categories of tests, and for specific analytes where possible. The
  3. 3. dollar value of a market segment is directly proportional to the number of testsperformed, because the cost of the instrumentation is generally buried in the per testprice.The report discusses tests and technologies that are currently available and those thatare expected to take their place. Generally, current products and technologies establishthe standard of care and its value to payers. Many of the assays and techniquespresented in the report are expected to replace the standard of care in 2007/08, but withhealthcare systems emphasis on cost/benefit analysis for new technologies adoption,the market value and thus penetration capabilities of newer approaches may be limited.Unsurpassed Breadth of CoverageThe information presented in this report is derived from publicly available informationsources such as company, government, and medical organization reports. The analysisis based on the authors industry knowledge combined with literature searches andinterviews with industry professionals and experts in the areas of in vitro diagnosticsand molecular pathologists. Companies profiled in this study include: Top Companies Abbott Diagnostics Becton, Dickinson and Company (BD) Beckman Coulter Inc. bioMerieux Inc. Celera Cepheid Dako A/S Digene Corporation Genomic Health Gen-Probe Inc. Genzyme Corporation Ortho Clinical Diagnostics (OCD) Qiagen N.V. Roche Diagnostics Siemens Medical Solutions Diagnostics Sysmex Corporation Ventana Medical Systems. Inc. Other Companies 23andMe, Inc. 454 Life Sciences Corporation AdnaGen AG Adnavance Technologies Inc. Advanced Analytical Technologies, Inc. (AATI) AdvanDx, Inc.
  4. 4. AffymetrixAgendia B.V.Agilent Technologies Inc.Almac Diagnostics (formerly ArraDx)Althea Technologies, Inc.Ambry Genetics CorporationArcxis BiotechnologiesAsuragen, Inc.Athena Diagnostics, Inc.Atlas Genetics LimitedAutoGenomics, Inc.AviaraDx (formerly Arcturus Biosciences)bcs BIOTECH S.p.A.BG MedicineBiocept, Inc.BioHelix CorporationBioNanomatrixBio-Reference Laboratories, Inc. (BRLI)Biotage AB (formerly Pyrosequencing Technologies)Biotools, B & M Labs, S.A.BioTrove, Inc.China Medical Technologies, Inc.Clarient Inc. (formerly ChromaVision)Clinical Data, Inc.CLONDIAG chip technologies GmbHCombiMatrix Molecular Diagnostics (CMDX)Consumer GeneticsCorrelogic Systems, Inc.Curidium Medica PlcdeCode Genetics Inc.DiaGenic ASADiatherix Laboratories Inc.DNAFORMDNA Direct, Inc.The DNA Repair Company (DNAR)DxS Ltd.eGene Inc.eGenomics, Inc.Eiken Chemical Co., LtdEnigma Diagnostics LimitedEpigenomics AGEpistem Ltd.Eppendorf Biochip Systems GmbHEraGen Biosciences Inc.EXACT Sciences CorporationExiqon A/S
  5. 5. Fluidigm CorporationFocus Diagnostics, Inc.Fujifilm Diagnostics (Fujifilm GmbH)Gene Express, Inc.GeneNews LimitedGenoID Ltd.GenomasGenoptix, Inc.GENPOINT ASGreiner Bio-One International AGHain Lifescience GmbHHamilton Thorne Biosciences, Inc.HandyLab, Inc.Health Discovery CorporationHiFi DNA Tech, LLCIkonisys Inc.IlluminaImmunicon CorporationInnogenetics NVInterGenetics, Inc.Interleukin Genetics, Inc.IntegraGen SAInvitrogen CorporationIpsogenIris BioTechnologies Inc.KREATECH Biotechnology B.V.Lab21 HealthcareLaboratory Corporation of America Holdings (LabCorp)Med BioGene, Inc. (MBI)Microchip Biotechnologies, Inc. (MBI)Microgen Bioproducts Ltd.Mobidiag OyMolzym GmbH & Co. KGMonogram Biosciences, Inc. (formerly ViroLogic)Myconostica, Ltd.Myriad Genetics, Inc.NanogenNanosphere, Inc.NavigenicsNeuroMarkNorDiag ASANovartis Vaccines and Diagnostics/ChironNuvera BiosciencesOncoMethylome Sciences S.A.Orchid CellmarkOrion Genomics
  6. 6. Osmetech plc Pacific Biosciences of California, Inc. (PacBio) ParagonDx LLC Pathwork Diagnostics (formerly Predicant Biosciences) Perceptronix Medical Inc. PerkinElmer, Inc. Prediction Sciences Prodesse, Inc. Progenika Biopharma Psynomics Incorporated Q Chip Ltd. Quest Diagnostics Incorporated Rosetta Genomics Ltd. Seegene, Inc. SensiGen LLC Sequenom, Inc. SIRS-Lab Smart Genetics Tepnel Life Sciences TessArae, LLC TheraGenetics, Limited Third Wave Technologies Inc. Transgenomic Inc. TrimGen Corporation Veredus Laboratories Pte Ltd. Veridex, LLC Vita Genomics Xceed Molecular XDx Inc. Xenomics, Inc. Zila, Inc.TABLE OF CONTENTSCHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Size and Growth of the Market Market Trends Regulatory Issues and Molecular Tests The Promise of Companion Diagnostics From Research to Clinic Test Services
  7. 7. CHAPTER TWO: TECHNOLOGICAL TRENDS Background The In Vitro/In Vivo Mix Miniaturization and Multiplexed Biological Assays The search for Non-Invasive Tools Mechanisms of Gene Modification, Regulation and Expression Methylated Gene (meDNA) Patterns RNA - Ribonucleic Acid Transcription Factors Circulating Cell-free Nucleic Acids Sample Preparation and System Automation PCR Patent UpdateCHAPTER THREE: MEDICAL TRENDS AND MARKET ISSUES Background New Testing Opportunities - Genes and Proteins Reimbursement of Novel Tests Medicare and Medicaid HMOs and Managed Care GTE Subscription Based Model Commercializing Molecular Diagnostics Increasing Efficiency Successful Patents Lab-Developed Test Services Regulatory Issues and Molecular Tests The Promise of Companion Diagnostics From Research to Clinic Test ServicesCHAPTER FOUR: TECHNOLOGICAL TRENDS THAT ENABLE THE FUTURE OFMOLECULAR DIAGNOSTICS Background The In Vitro/In Vivo Mix Miniaturization and Multiplexed Biological Assays Microfluidic Devices Bead-Based Technologies The Search For Non-Invasive Tools o Breath o Hair o Serum Mechanisms of Gene Modification, Regulation and Expression o Methylated Gene (meDNA) Patterns o RNA - Ribonucleic Acid
  8. 8. o Transcription Factors o Circulating Cell-free Nucleic Acids Sample Preparation and System Automation Homebrew Reagents DNA Test Sample Preparation Market PCR Patent UpdateCHAPTER FIVE: PLATFORMS AT THE FOREFRONT OF MOLECULAR ASSAYS Background Components of DNA tests Molecular Test Platforms Market Overview o Polymerase Chain Reaction (PCR) o Non-PCR Amplification Technologies o Miniaturized Platforms - Arrays and Biochips o Mass Spectroscopy o Laser Capture Microdissection (LCM) and Tissue Arrays o TMAsCHAPTER SIX: MARKET ANALYSIS Worldwide Opportunities for Molecular Tests o The United States o Europe o China Molecular Diagnostics And Target Markets The Market for Molecular Assays in Cancer Management o CUP/TUO o Herceptin The Market for Molecular Assays In Hematology o Towards Routine Hematology Testing The Market For Molecular Assays in Coagulation o Procoagulation and Thrmobolytic Markers o Warfarin The Market For Molecular Assays in Histopathology/Cytology o Overview o The Future of the Pap Smear & HPV Testing o In Situ Hybridization and Digital Cytometry o Microscopy The Market for Molecular Assays in Microbiology/Virology o HIV o STDs o Hospital Acquired Infections (HAIs) o Respiratory Viruses The Market for Molecular Assays in Blood Transfusion Medicine o Transfusion Statistics
  9. 9. o Trends in Transfusion Medicine o Blood Screening Markets o PROCLEIX The Market for Molecular Assays in Tissue Transplant Management The Market for Molecular Assays in Prenatal and Neonatal Testing o Prental Carrier and Fetus Screening Market o FISH Assays o PAP Assays o IVF Fertilization Procedure Testing The Market for Molecular Assays for Inherited Diseases Pharmacodiagnostic Test ApplicationsCHAPTER SEVEN: MAJOR VENDORS AND COMPANIES TO WATCH Company Triage The Majors The Stars Participants Newcomers 2012 and Beyond Acquisitions, Alliances and Collaborations in Molecular DiagnosticsCHAPTER EIGHT: CONCLUSIONS AND STRATEGIC IMPLICATIONS Conclusion One o Implication Conclusion Two o Implication Conclusion Three o Implication Conclusion Four o Implication Conclusion Five o Implication Conclusion Six o Implication
  10. 10. CHAPTER NINE: MAJOR VENDORS AND COMPANIES TO WATCH Top Companies Abbott Diagnostics o Revenues o Key Comment o Details Becton, Dickinson and Company (BD) o Revenues o Key Comment o Details Beckman Coulter Inc. o Revenues o Key Comment o Details bioMerieux Inc. o Revenues o Key Comment o Details Celera o Revenues o Key Comment o Details Cepheid o Revenues o Key Comment o Details Dako A/S o Revenues o Key Comment o Details Digene Corporation o Revenues o Key Comment o Details Genomic Health o Revenues o Key Comment o Details Gen-Probe Inc. o Revenues o Key Comment o Details Genzyme Corporation o Revenues o Key Comment
  11. 11. o DetailsOrtho Clinical Diagnostics (OCD) o Revenues o Key Comment o DetailsQiagen N.V. o Revenues o Key Comment o DetailsRoche Diagnostics o Revenues o Key Comment o DetailsSiemens Medical Solutions Diagnostics o Revenues o Key Comment o DetailsSysmex Corporation o Revenues o Key Comment o DetailsVentana Medical Systems. Inc. o Revenues o Key Comment o DetailsOther Companies23andMe, Inc. o Revenues o Key Comment o Details454 Life Sciences Corporation o Revenues o Key Comment o DetailsAdnaGen AG o Revenues o Key Comment o DetailsAdnavance Technologies Inc. o Revenues o Key Comment o DetailsAdvanced Analytical Technologies, Inc. (AATI) o Revenues
  12. 12. o Key Comment o DetailsAdvanDx, Inc. o Revenues o Key Comment o DetailsAffymetrix o Revenues o Key Comment o DetailsAgendia B.V. o Revenues o Key Comment o DetailsAgilent Technologies Inc. o Revenues o Key Comment o DetailsAlmac Diagnostics (formerly ArraDx) o Revenues o Key Comment o DetailsAlthea Technologies, Inc. o Revenues o Key Comment o DetailsAmbry Genetics Corporation o Revenues o Key Comment o DetailsArcxis Biotechnologies o Revenues o Key Comment o DetailsAsuragen, Inc. o Revenues o Key Comment o DetailsAthena Diagnostics, Inc. o Revenues o Key Comment o DetailsAtlas Genetics Limited o Revenues o Key Comment o Details
  13. 13. AutoGenomics, Inc. o Revenues o Key Comment o DetailsAviaraDx (formerly Arcturus Biosciences) o Revenues o Key Comment o Detailsbcs BIOTECH S.p.A. o Revenues o Key Comment o DetailsBG Medicine o Revenues o Key Comment o DetailsBiocept, Inc. o Revenues o Key Comment o DetailsBioHelix Corporation o Revenues o Key Comment o DetailsBioNanomatrix o Revenues o Key Comment o DetailsBio-Reference Laboratories, Inc. (BRLI) o Revenues o Key Comment o DetailsBiotage AB (formerly Pyrosequencing Technologies) o Revenues o Key Comment o DetailsBiotools, B & M Labs, S.A. o Revenues o Key Comment o DetailsBioTrove, Inc. o Revenues o Key Comment o DetailsChina Medical Technologies, Inc. o Revenues
  14. 14. o Key Comment o DetailsClarient Inc. (formerly ChromaVision) o Revenues o Key Comment o DetailsClinical Data, Inc. o Revenues o Key Comment o DetailsCLONDIAG chip technologies GmbH o Revenues o Key Comment o DetailsCombiMatrix Molecular Diagnostics (CMDX) o Revenues o Key Comment o DetailsConsumer Genetics o Revenues o Key Comment o DetailsCorrelogic Systems, Inc. o Revenues o Key Comment o DetailsCuridium Medica Plc o Revenues o Key Comment o DetailsdeCode Genetics Inc. o Revenues o Key Comment o DetailsDiaGenic ASA o Revenues o Key Comment o DetailsDiatherix Laboratories Inc. o Revenues o Key Comment o DetailsDNAFORM o Revenues o Key Comment o Details
  15. 15. DNA Direct, Inc. o Revenues o Key Comment o DetailsThe DNA Repair Company (DNAR) o Revenues o Key Comment o DetailsDxS Ltd. o Revenues o Key Comment o DetailseGene Inc. o Revenues o Key Comment o DetailseGenomics, Inc. o Revenues o Key Comment o DetailsEiken Chemical Co., Ltd o Revenues o Key Comment o DetailsEnigma Diagnostics Limited o Revenues o Key Comment o DetailsEpigenomics AG o Revenues o Key Comment o DetailsEpistem Ltd. o Revenues o Key Comment o DetailsEppendorf Biochip Systems GmbH o Revenues o Key Comment o DetailsEraGen Biosciences Inc. o Revenues o Key Comment o DetailsEXACT Sciences Corporation o Revenues
  16. 16. o Key Comment o DetailsExiqon A/S o Revenues o Key Comment o DetailsFluidigm Corporation o Revenues o Key Comment o DetailsFocus Diagnostics, Inc. o Revenues o Key Comment o DetailsFujifilm Diagnostics (Fujifilm GmbH) o Revenues o Key Comment o DetailsGene Express, Inc. o Revenues o Key Comment o DetailsGeneNews Limited o Revenues o Key Comment o DetailsGenoID Ltd. o Revenues o Key Comment o DetailsGenomas o Revenues o Key Comment o DetailsGenoptix, Inc. o Revenues o Key Comment o DetailsGENPOINT AS o Revenues o Key Comment o DetailsGreiner Bio-One International AG o Revenues o Key Comment o Details
  17. 17. Hain Lifescience GmbH o Revenues o Key Comment o DetailsHamilton Thorne Biosciences, Inc. o Revenues o Key Comment o DetailsHandyLab, Inc. o Revenues o Key Comment o DetailsHealth Discovery Corporation o Revenues o Key Comment o DetailsHiFi DNA Tech, LLC o Revenues o Key Comment o DetailsIkonisys Inc. o Revenues o Key Comment o DetailsIllumina o Revenues o Key Comment o DetailsImmunicon Corporation o Revenues o Key Comment o DetailsInnogenetics NV o Revenues o Key Comment o DetailsInterGenetics, Inc. o Revenues o Key Comment o DetailsInterleukin Genetics, Inc. o Revenues o Key Comment o DetailsIntegraGen SA o Revenues
  18. 18. o Key Comment o DetailsInvitrogen Corporation o Revenues o Key Comment o DetailsIpsogen o Revenues o Key Comment o DetailsIris BioTechnologies Inc. o Revenues o Key Comment o DetailsKREATECH Biotechnology B.V. o Revenues o Key Comment o DetailsLab21 Healthcare o Revenues o Key Comment o DetailsLaboratory Corporation of America Holdings (LabCorp) o Revenues o Key Comment o DetailsMed BioGene, Inc. (MBI) o Revenues o Key Comment o DetailsMicrochip Biotechnologies, Inc. (MBI) o Revenues o Key Comment o DetailsMicrogen Bioproducts Ltd. o Revenues o Key Comment o DetailsMobidiag Oy o Revenues o Key Comment o DetailsMolzym GmbH & Co. KG o Revenues o Key Comment o Details
  19. 19. Monogram Biosciences, Inc. (formerly ViroLogic) o Revenues o Key Comment o DetailsMyconostica, Ltd. o Revenues o Key Comment o DetailsMyriad Genetics, Inc. o Revenues o Key Comment o DetailsNanogen o Revenues o Key Comment o DetailsNanosphere, Inc. o Revenues o Key Comment o DetailsNavigenics o Revenues o Key Comment o DetailsNeuroMark o Revenues o Key Comment o DetailsNorDiag ASA o Revenues o Key Comment o DetailsNovartis Vaccines and Diagnostics/Chiron o Revenues o Key Comment o DetailsNuvera Biosciences o Revenues o Key Comment o DetailsOncoMethylome Sciences S.A. o Revenues o Key Comment o DetailsOrchid Cellmark o Revenues
  20. 20. o Key Comment o DetailsOrion Genomics o Revenues o Key Comment o DetailsOsmetech plc o Revenues o Key Comment o DetailsPacific Biosciences of California, Inc. (PacBio) o Revenues o Key Comment o DetailsParagonDx LLC o Revenues o Key Comment o DetailsPathwork Diagnostics (formerly Predicant Biosciences) o Revenues o Key Comment o DetailsPerceptronix Medical Inc. o Revenues o Key Comment o DetailsPerkinElmer, Inc. o Revenues o Key Comment o DetailsPrediction Sciences o Revenues o Key Comment o DetailsProdesse, Inc. o Revenues o Key Comment o DetailsProgenika Biopharma o Revenues o Key Comment o DetailsPsynomics Incorporated o Revenues o Key Comment o Details
  21. 21. Q Chip Ltd. o Revenues o Key Comment o DetailsQuest Diagnostics Incorporated o Revenues o Key Comment o DetailsRosetta Genomics Ltd. o Revenues o Key Comment o DetailsSeegene, Inc. o Revenues o Key Comment o DetailsSensiGen LLC o Revenues o Key Comment o DetailsSequenom, Inc. o Revenues o Key Comment o DetailsSIRS-Lab o Revenues o Key Comment o DetailsSmart Genetics o Revenues o Key Comment o DetailsTepnel Life Sciences o Revenues o Key Comment o DetailsTessArae, LLC o Revenues o Key Comment o DetailsTheraGenetics, Limited o Revenues o Key Comment o DetailsThird Wave Technologies Inc. o Revenues
  22. 22. o Key Comment o Details Transgenomic Inc. o Revenues o Key Comment o Details TrimGen Corporation o Revenues o Key Comment o Details Veredus Laboratories Pte Ltd. o Revenues o Key Comment o Details Veridex, LLC o Revenues o Key Comment o Details Vita Genomics o Revenues o Key Comment o Details Xceed Molecular o Revenues o Key Comment o Details XDx Inc. o Revenues o Key Comment o Details Xenomics, Inc. o Revenues o Key Comment o Details Zila, Inc. o Revenues o Key Comment o Details Other ParticipantsAvailable immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=1914575
  23. 23. US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004

×